China Resources
12
10M
12
0.14
1
2
- Areas of investment
Summary
In 1938 was created China Resources, which is appeared as Corporate Investor. The fund was located in Asia if to be more exact in Hong Kong. The leading representative office of defined Corporate Investor is situated in the Wan Chai.
The overall number of key employees were 8.
The top activity for fund was in 2018. The top amount of exits for fund were in 2018. The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 deals per year. This China Resources works on 9 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this Corporate Investor is 20 percentage points more often commits exit comparing to other organizations.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Meituan-Dianping, Souzhou Ribo Life Science We can highlight the next thriving fund investment areas, such as Medical, Real Estate. The fund has specific favorite in a number of founders of portfolio startups. For fund there is no match between the location of its establishment and the land of its numerous investments - China.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the China Resources, startups are often financed by Temasek Holdings, Capital Today, Trustbridge Partners. The meaningful sponsors for the fund in investment in the same round are TusPark Ventures, SDIC Fund Management, Macquarie Bank. In the next rounds fund is usually obtained by Wendi Murdoch, Trustbridge Partners, Tencent Holdings.
Investments analytics
Analytics
- Total investments
- 12
- Lead investments
- 1
- Exits
- 2
- Rounds per year
- 0.14
- Investments by industry
- Medical (3)
- Food and Beverage (3)
- Health Care (2)
- Software (2)
- Snack Food (2) Show 21 more
- Investments by region
-
- China (10)
- Australia (1)
- Sweden (1)
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 2
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 17B
- Group Appearance index
- 0.58
- Strategy success index
- 0.10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Suzhou Ribo Life Science | 20 Mar 2017 | Biotechnology, Genetics, Medical | Early Stage Venture | 41M | Anhui, China, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.